By XANTHA LEATHAM FOR THE DAILY MAIL PUBLISHED: 20:08 EST, 13 February 2022 | UPDATED: 20:08 EST, 13 February 2022 A test that spots dangerous prostate cancer tumours has been developed by doctors. Current methods mean that differentiating between harmless and aggressive prostate tumours is incredibly difficult – especially at an early stage. For some men, the tumour can be...
By JONATHAN CHADWICK FOR MAILONLINE PUBLISHED: 09:00 EDT, 2 July 2021 | UPDATED: 09:17 EDT, 2 July 2021 Aspirin is commonly known as a cheap and effective over-the-counter painkiller, but a new study suggests it is also a successful cancer treatment option too. Academics at Cardiff University carried out a review of prior observational studies in patients with 18 different...
by University of East Anglia Researchers at the University of East Anglia have discovered why some prostate cancers are more aggressive, spread to different parts of the body, and ultimately cause death It is hoped that the discovery, published today, could transform patient treatment. The findings come after the same team developed a test that...
By Nick Lavars Treating prostate cancer through traditional means such as surgery or radiotherapy carries certain risks, with some patients experiencing impotence, urinary problems and bowel trouble, among other unwanted side effects. Safer and less invasive treatment options could soon be on the table, however, including a novel MRI-guided ultrasound technique that eliminated significant cancers in...
by McGill University Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia What molecular event happens for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet? This is the question Dr. David P. Labbé, a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC),...
A group of men with especially aggressive prostate cancer may respond unusually well to immunotherapy, a major new study reports. Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia The research offers the possibility of effective treatment for men with prostatecancer who currently die from their disease much more rapidly...
Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual...
